IgM Antibody Purification Pathway

Immunoglobulin M (IgM), the largest and most structurally complex member of the antibody family, has recently reemerged in the spotlight of biopharmaceutical research and development. However, it is precisely the polymeric structure that endows IgM with its powerful immune functions that makes its downstream purification a significant technical challenge.

Today, we will systematically review the purification strategies for IgM, aiming to help researchers identify the most suitable purification pathway for their needs.

Three Major Challenges in IgM Purification

Unlike the mature, standardized purification processes for IgG, the downstream processing of IgM must overcome several significant obstacles:

01 Structural Instability, Prone to Aggregation and Degradation

The pentameric/hexameric structure of IgM requires correct folding and assembly, placing high demands on the expression environment. During the purification process, changes in conditions such as salt concentration, pH, and temperature can lead to conformational changes, resulting in aggregation or degradation.

02 Large Molecular Size, Mass Transfer Limitations

The enormous size of IgM (900-1050 kDa) leads to an extremely slow diffusion coefficient—about half that of IgG. This means that, on traditional porous chromatography media, achieving comparable load capacity and separation efficiency requires a flow rate reduction by half.

03 Narrow Solubility Window, Sensitive to Conditions

IgM has a narrower solubility range compared to IgG and is more sensitive to changes in pH and salt concentration. Extreme pH conditions can lead to increased turbidity or even precipitation. The low-pH elution conditions required for affinity chromatography often cause recovery rate issues in large-scale production.

Mainstream IgM Purification Pathways

Currently, IgM purification primarily revolves around the following strategies:

01 Pathway 1: Affinity Chromatography

Affinity chromatography is theoretically the most selective purification method, and in recent years, various affinity schemes suitable for IgM have emerged:

Protein A/L Affinity

The Fc region of IgM has significant steric hindrance, making traditional Protein A ineffective. However, Protein A can capture IgM by binding to the heavy chain variable region encoded by the VH3 gene, while Protein L can recognize the κ light chain region, making it suitable for natural or recombinant IgM. MaXtar^® Protein L, through modifications to the Protein L ligand, improves load capacity, resolution, and alkali resistance, achieving a dynamic load capacity of 10 mg/mL and retaining good activity.

Thiol Affinity

Utilizing the numerous disulfide bonds in the IgM molecule, thiol affinity media based on 2-mercaptopyridine ligands (e.g., MaXtar^® Plasmidcap HR) can efficiently purify IgM, with high recovery rates and good activity retention.

Advantages: High purity product obtained in a single-step purification.

Limitations: Low-pH elution conditions may affect IgM stability, and affinity ligands can be expensive.

02 Pathway 2: Ion Exchange Chromatography

Ion exchange is a commonly used non-affinity strategy for IgM purification. Most IgM monoclonal antibodies have a high charge density, allowing them to bind well to cation exchange resins under neutral pH conditions, supporting higher binding capacity. This method does not face issues with ligand dissociation, and load capacity can reach tens of mg/mL, but its selectivity is relatively limited, making it difficult to fully separate different types of antibodies.

03 Pathway 3: Mixed-Mode Chromatography

Mixed-mode chromatography combines various interactions such as ion exchange, hydrophobic interactions, and hydrogen bonding within a single medium, which has shown distinct advantages in IgM purification in recent years.

Cation Exchange + Hydrophobic Mode

Capture is performed using MaXtar^® MMC, and polishing is done using BARONHAP^® Type II ceramic hydroxyapatite media. This non-affinity platform strategy works well for both neutral and basic IgM, offering a simple, scalable, and efficient process.

Case Study: Using BARONHAP^® Type II Removal of Dimer Impurities.

Figure 1: Chromatogram

Experimental Conditions:

• Equilibration Buffer: 5 mM PB, pH 7.5

• Elution Buffer: 400 mM PB, pH 7.5

• Load Mass: 17.5 mg/mL

• Flow Rate: 1 mL/min

• Elution: 0-100% B, 20 CV

Figure 2: Electrophoresis Profile

Core–Shell Structured Mixed-Mode

In most cases, a single-step affinity chromatography is insufficient to meet purity requirements—especially for native IgM samples derived from serum or ascites, where the aforementioned affinity media cannot effectively distinguish IgM from other antibody types. Given the large molecular weight of IgM, a second purification step based on size differences can be applied. Mixed-mode chromatography with a core–shell structure is a typical solution. Its արտաքին inert shell allows precise control of pore size (700 kDa or 400 kDa cutoff). Target IgM molecules, being larger than the cutoff, pass through directly, while smaller impurities enter the core and are removed via adsorption by multimodal ligands. Compared with traditional size-exclusion chromatography, this approach offers up to 10× higher loading capacity and flow rates of 250–300 cm/h, significantly improving production efficiency. When combined with ammonium sulfate fractionation for pre-enrichment, this mixed-mode strategy can increase the purity of mouse ascites-derived IgM to over 95%.

Advantages: Mild operating conditions and relatively low cost.

Limitations: Low processing throughput, not suitable for large-scale production, and involves cumbersome steps with limited yield for large quantities of antibodies.

How to Choose the Most Suitable Purification Strategy?

The selection strategy is recommended as follows:

01 IgM from Ascites/Serum Sources

Recommended Route: Ammonium sulfate fractionation + mixed-mode chromatography (flow-through mode)

Key Considerations: IgM concentration in ascites is high but contains many impurity proteins. Salt precipitation is first used for enrichment, followed by polishing with core–shell media, achieving purity above 95%.

02 Recombinant/Hybridoma-Expressed IgM

Recommended Route: Affinity chromatography (Protein L/thiophilic affinity) or a two-step process of CEX + mixed-mode polishing

Key Considerations: Samples are relatively clean, making one-step affinity capture highly efficient. If activity is sensitive, a non-affinity platform is recommended.

Summary

Although IgM purification presents significant challenges, these obstacles are gradually being overcome with the emergence of novel chromatography media and process strategies. Whether it is high-selectivity affinity chromatography, high-capacity ion exchange, or multifunctional mixed-mode chromatography, each method has its unique application scenarios. The key lies in selecting the most appropriate combination of purification strategies based on the specific sample source, target purity, and scale requirements.

As a professional supplier of chromatography media, BioLink offers a full range of products covering affinity, ion exchange, and mixed-mode chromatography, along with process development consulting and technical support. If you have IgM purification needs, feel free to contact us.

This article is intended for technical exchange and reference only. Specific purification processes should be validated and optimized based on actual conditions.